Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arya Biragyn

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Seminars in Immunopathology|January 16, 2019
Correction to: Potential importance of B cells in aging and aging-associated neurodegenerative diseasesArya Biragyn, Maria Aliseychik, Evgeny Rogaev
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2014
Generation and identification of tumor-evoked regulatory B cellsArya Biragyn, Catalina Lee-Chang, Monica Bodogai
Brain, Behavior, and Immunity|November 4, 2018
Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse modelTomer Illouz, Ravit Madar, Arya Biragyn, et al.
Vaccine|July 23, 2021
Induction of an effective anti-Amyloid-β humoral response in aged miceTomer Illouz, Ravit Madar, Tamir Hirsh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptorsDolgor Baatar, Purevdorj Olkhanud, Dianne Newton, et al.
Trends in Immunology|June 20, 2002
Mammalian defensins in immunity: more than just microbicidalDe Yang, Arya Biragyn, Larry W Kwak, et al.
Haematologica|September 10, 2002
Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccinesPier Adelchi Ruffini, Sattva S Neelapu, Larry W Kwak, et al.
Journal for Immunotherapy of Cancer|December 27, 2016
Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma modelJames T Gordy, Kun Luo, Hong Zhang, et al.
Annual Review of Immunology|March 23, 2004
Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defenseDe Yang, Arya Biragyn, David M Hoover, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasLDolgor Baatar, Purevdorj Olkhanud, Kenya Sumitomo, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Seminars in Immunopathology|January 16, 2019
Correction to: Potential importance of B cells in aging and aging-associated neurodegenerative diseasesArya Biragyn, Maria Aliseychik, Evgeny Rogaev
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2014
Generation and identification of tumor-evoked regulatory B cellsArya Biragyn, Catalina Lee-Chang, Monica Bodogai
Brain, Behavior, and Immunity|November 4, 2018
Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse modelTomer Illouz, Ravit Madar, Arya Biragyn, et al.
Vaccine|July 23, 2021
Induction of an effective anti-Amyloid-β humoral response in aged miceTomer Illouz, Ravit Madar, Tamir Hirsh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptorsDolgor Baatar, Purevdorj Olkhanud, Dianne Newton, et al.
Trends in Immunology|June 20, 2002
Mammalian defensins in immunity: more than just microbicidalDe Yang, Arya Biragyn, Larry W Kwak, et al.
Haematologica|September 10, 2002
Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccinesPier Adelchi Ruffini, Sattva S Neelapu, Larry W Kwak, et al.
Journal for Immunotherapy of Cancer|December 27, 2016
Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma modelJames T Gordy, Kun Luo, Hong Zhang, et al.
Annual Review of Immunology|March 23, 2004
Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defenseDe Yang, Arya Biragyn, David M Hoover, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasLDolgor Baatar, Purevdorj Olkhanud, Kenya Sumitomo, et al.
Pageof 9